Video

Lemtrada's Benefits Can Help Multiple Sclerosis Patients Where Others Have Failed

Author(s):

In a longterm condition like multiple sclerosis finding the proper treatment option can often be a difficult task. A medication was recently approved to help patients who have struggled to find that help in the past.

In a longterm condition like multiple sclerosis finding the proper treatment option can often be a difficult task. A medication was recently approved to help patients who have struggled to find that help in the past.

Ann Bass, MD, from the Neurology Center of San Antonio discussed the advantages and potential risks of the medication at the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers in Indianapolis. Bass said the medication is given in two stages over the course of two years and many patients do not need a third dose after that making it an attractive option.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.